亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Dose adherence and baseline exposure analysis of the ibrutinib 420 mg dose administered to patients with previously treated chronic lymphocytic leukemia (CLL).

医学 伊布替尼 最大值 内科学 药代动力学 胃肠病学 加药 慢性淋巴细胞白血病 泌尿科 外科 白血病
作者
Paul M. Barr,Jennifer R. Brown,Peter Hillmen,Susan O’Brien,Jacqueline C. Barrientos,Nishitha Reddy,Steven Coutré,Stephen P. Mulligan,Ulrich Jäger,Richard R. Furman,Florence Cymbalista,Marco Montillo,Claire Dearden,Tadeusz Robak,Carol Moreno,John M. Pagel,Jan A. Burger,Samuel Suzuki,Danelle F. James,John C. Byrd
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:33 (15_suppl): 7012-7012 被引量:3
标识
DOI:10.1200/jco.2015.33.15_suppl.7012
摘要

7012 Background: Ibrutinib (ibr), a first-in-class, once-daily, oral, covalent inhibitor of Bruton’s tyrosine kinase (BTK), is rapidly eliminated from plasma after oral administration (Advani, JCO 2013). Complete or near complete BTK active site occupancy (median > 90%) is achieved at 4 hours and maintained at 24 hours with ibr 420 mg once-daily (O’Brien, Lancet Oncology 2013). At 140 or 280 mg doses, fewer patients (pts) attained complete BTK occupancy (Poggesi, AACR 2014). This analysis evaluated the effect of the ibr 420 mg once-daily dose on IRC-assessed progression-free survival (PFS) in pts with previously treated CLLfrom thephase 3 RESONATE trial. Methods: Dose intensity (DI) was defined as the proportion of actually administered vs planned doses of 420 mg. DI was also defined in first 8 weeks to compare statistically with post-week 8 PFS. Steady-state AUC/Cmax was estimated per NONMEM modeling using 2 timepoint samples (weeks 1 and 4). Missed doses had to be consecutive. Results: Ibr-treated pts (n = 195) had a mean DI of 95% (median 100%) with 8.3 months of treatment. The majority of dose interruptions restarted at 420 mg; 3.6% of pts had 1 and 0.5% had 2 dose reductions due to AEs. Pts with higher DI experienced longer PFS (median NR) compared to lower DI (11 months). Using an adjusted mean DI of 96% in first 8 weeks and post week-8 PFS, this trend was confirmed with HR = 0.4 (P= 0.0127). Pts with higher DI had a lower rate of progression regardless of del17p, p53 mutation, or del11q CLL. In 179 pts receiving ibr 420 mg with PK assessment at weeks 1 and 4, no difference was seen in median PFS with lower vs higher ibr exposure (AUC or Cmax). There were fewer PFS events in pts not missing (n = 136) vs those missing (n = 59) ibr doses for ≥ 8 consecutive days (13% vs 31%, respectively), with median PFS of NR vs 11 months, respectively. The mean duration of these missed doses was 26 days. Conclusions: A higher mean dose intensity of ibr is associated with improved PFS, with patients missing more than 1 week of treatment experiencing more PFS events. These results, and the established clinical profile, support the clinical utility of sustained adherence to the once-daily 420 mg dose of ibr in patients with previously treated CLL. Clinical trial information: NCT01578707.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
八合一发布了新的文献求助10
1秒前
外星人发布了新的文献求助10
4秒前
josephina发布了新的文献求助10
5秒前
CAOHOU给SimonLee的求助进行了留言
8秒前
程宇应助吴DrYDYY采纳,获得20
26秒前
冷酷完成签到,获得积分10
29秒前
wanci应助远方采纳,获得10
29秒前
32秒前
哈哈哈哈哈哈哈完成签到,获得积分10
32秒前
oleskarabach完成签到,获得积分20
33秒前
佛系完成签到 ,获得积分10
33秒前
李治稳发布了新的文献求助10
37秒前
子咸发布了新的文献求助10
39秒前
oleskarabach发布了新的文献求助10
40秒前
程风破浪发布了新的文献求助50
47秒前
yangl完成签到 ,获得积分10
54秒前
josephina完成签到,获得积分10
58秒前
田様应助清脆的绮梅采纳,获得10
59秒前
查文献的大猫完成签到,获得积分10
1分钟前
1分钟前
sola完成签到 ,获得积分10
1分钟前
伯爵的猫完成签到,获得积分10
1分钟前
勤恳的断秋完成签到 ,获得积分10
1分钟前
程宇给cccccl的求助进行了留言
1分钟前
程风破浪完成签到,获得积分10
1分钟前
不羁完成签到 ,获得积分10
1分钟前
he完成签到,获得积分10
1分钟前
jueshadi发布了新的文献求助10
1分钟前
丁静完成签到 ,获得积分10
1分钟前
蛋黄啵啵完成签到 ,获得积分10
1分钟前
宋子琛完成签到,获得积分10
1分钟前
momoni完成签到 ,获得积分10
1分钟前
orixero应助Oo采纳,获得10
1分钟前
he发布了新的文献求助10
1分钟前
oleskarabach发布了新的文献求助10
1分钟前
chenzy完成签到,获得积分10
1分钟前
1分钟前
传奇3应助科研通管家采纳,获得10
2分钟前
领导范儿应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Social Research Methods (4th Edition) by Maggie Walter (2019) 1030
A new approach to the extrapolation of accelerated life test data 1000
Indomethacinのヒトにおける経皮吸収 400
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 370
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3994955
求助须知:如何正确求助?哪些是违规求助? 3535071
关于积分的说明 11267066
捐赠科研通 3274842
什么是DOI,文献DOI怎么找? 1806483
邀请新用户注册赠送积分活动 883335
科研通“疑难数据库(出版商)”最低求助积分说明 809762